You will have introduction to infective, inflammatory and degenerative conditions in neurological practice. The neurological topics covered include...

Neurodegenerative, Infectious and Inflammatory Diseases of the Nervous System - Basic (CLNE0013)

You will have introduction to infective, inflammatory and degenerative conditions in neurological practice. The neurological topics covered include neurological Infections, neuro-inflammatory diseases, neurodegeneration, movement disorders, and neuromuscular diseases.

Learning is through online interactive lectures and will be facilitated through tutor and student interactions through the online forums.

On completion of the module, you will be able to recognise and plan management of infectious and degenerative neurological conditions such as Multiple sclerosis, encephalitis, neuropathies, myasthenia, Parkinson’s disease, Alzheimer’s disease and understand the common differential diagnosis of these conditions.

PAEDIATRIC ONCOLOGY|TEEN AND YOUNG ADULTS CANCER

Scientific and clinical research has revolutionised the treatment of childhood and TYA (Teen and Young Adults) cancer, resulting in vastly improved outcomes....

Paediatric and Young Adult Cancer: Basic Research and Clinical Applications (CINS0012)

Scientific and clinical research has revolutionised the treatment of childhood and TYA (Teen and Young Adults) cancer, resulting in vastly improved outcomes. However, still too many lives are lost to cancer, underlining the importance of developing novel therapies for those cancers that are resistant to current therapy. In this module, you will be taught by scientists and clinicians who study the molecular mechanisms of childhood and TYA cancers, treat patients diagnosed with cancer and develop new therapies.

Incorporating lectures on the biology of this specific group of cancers and case studies, the module will illustrate the current state and future directions of childhood and TYA cancer research. Lectures will cover topics such as the impact of genomics on the molecular classification of brain cancer, the use of CAR-T cells in novel therapies, precision medicine and drug development, and experimental cancer models.